Among the 15 protein fingerprint that correlated with the prevalence of emphysema and the incidence of exacerbations, FGF-16, a growth factor contributing to tissue regeneration [42, 43], may represent a starting point for the development of new therapeutics. The gene discussed is FGF16; the disease is pulmonary emphysema.